NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 Status TERMINATED Phase PHASE3
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection Status TERMINATED Phase PHASE2
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM) Status COMPLETED Phase PHASE4
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease Status COMPLETED Phase PHASE4
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis Status COMPLETED Phase PHASE3
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian Children Status COMPLETED Phase N/A
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment Status COMPLETED Phase PHASE3
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir) Status COMPLETED Phase NA
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Status COMPLETED Phase PHASE4
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy Status COMPLETED Phase PHASE3
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Status COMPLETED Phase PHASE3
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease Status TERMINATED Phase PHASE2
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) Status TERMINATED Phase PHASE2